OptiBiotix Health

255927-opti_SlimBiome-delivers-fast-acting-and-measurable-results-e1747304268931-1024x708

Slimbiome

Subscribe to our investor alert service and receive all press releases, financial results and other key shareholder messages as soon as they become available.

Products

Microbiome Modulators posters

SweetBiotix Publications

SlimBiome/LeanBiome/OptiBiome Publications

WellBiome Publications

[Header] Publications

Partner Products

Global Partners

Leadership Team

Corporate [Header]

Contact Us

Shareholder Information

Advisors

Commercial Strategy

Market Context

Annual & Interim Reports

Corporate Governance

AIM Rule 26

Investors

Webinars

Announcements

Media & Presentations

News

Home

First & Second Generation Products

The Science

The Human Microbiome

Microbiome Market Potential

Technology

PT Sans

OptiBiotix Health caught up with Bob Rastall, Professor of Food Biotechnology at the University of Reading to discuss the importance fibre has within functional foods, and the role it plays on our health & wellbeing, with a key focus on our gut (via the microbiome).

Science-Backed Hunger and Craving Control 


Crush cravings. Stay full. Lose weight naturally.

A patented, award-winning ingredient designed to naturally reduce hunger and cravings—helping consumers manage weight effectively and sustainably.

SlimBiome® offers a natural, scientifically supported, non-pharmaceutical approach to reduce hunger and cravings. Developed in collaboration with leading UK universities and key opinion leaders in gut health and appetite regulation, it supports a healthier, more balanced lifestyle by targeting the microbiome and appetite control mechanisms.

SlimBiome® is a synergistic blend of natural prebiotic fibers and essential minerals that:

 by increasing stomach viscosity and slowing gastric emptying—mimicking GLP-1 activity

 by enhancing microbiome diversity and encouraging lean-body-associated bacterial growth

Four independent human intervention trials have shown consistently that SlimBiome® manages hunger and cravings and promotes a diverse, ‘lean’ microbiome:

Two double-blind, placebo-controlled, crossover, human intervention studies demonstrated a significant decreases in hunger and increases in fullness in individuals taking SlimBiome®. Participants who took 3g of SlimBiome® experienced significantly less hunger and felt fuller compared to the placebo both immediately and after 2.5 hours after consuming SlimBiome®.

A parallel, double-blind, placebo-controlled human study performed by Oxford Brookes University on volunteers who took SlimBiome® combined with healthy eating over a 4-week period have also shown it to help control overeating.

In a prospective, open-label human study performed by the University of Roehampton, using a meal replacement diet plan over 4 weeks SlimBiome® reduced fat mass by 5.4%, body fat by 2.8% and saw significant reductions in hip, waist and BMI whilst maintaining muscle mass. 

With the introduction of the GLP-1 obesity drugs the concept of managing hunger and cravings naturally has become an area of fast-growing interest. This has seen SlimBiome® becoming increasingly associated with large international brands looking to offer a healthier and sustainable approach to weight management.

SlimBiome® is highly adaptable, making it ideal for integration into a wide range of functional foods and supplements:

 Sachets, snack bars, shakes, soups, bakery, dairy products and more

 Heat-stable, neutral taste, cost-effective, easy to incorporate during manufacturing

four independent human intervention studies

 across Europe, North America, Canada, Australia, and New Zealand—helping brand partners differentiate in a competitive weight management market.

✉️ Contact us to explore bulk ingredient or private label product solutions: 

Independent human studies have shown that SlimBiome® delivers fast-acting and measurable results:

(Observed within 2.5 hours post-consumption)

Extended use over 4 weeks further demonstrated: 

Restoration of a healthy gut microbiome, including increased presence of lean-associated bacteria (e.g. Christensenella, Bacteroides)